Minerva Neurosciences, Inc. (NERV) stock
NERVNasdaqPharmaceutical PreparationsFiscal year ends December 31
Số liệu tài chính tới Q2 năm tài chính 2026, quý kết thúc ngày Jun 30, 2026Last filing: 10-Q on Nov 6, 2026Score 5/30
$2.18+0.02 (+0.93%)
Close on Nov 18, 2026Market cap $104.09MP/E –Yield –
Minerva Neurosciences operating cash flow
Operating cash flow is the cash the business generates from its day-to-day operations.
Minerva Neurosciences's operating cash flow for the twelve months ending Jun 30, 2026 was -$26.17M. For fiscal 2025 it was -$13.51M. The highest annual figure on record is $3.09M in fiscal 2017.
Annual operating cash flow
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2025 | Dec 31, 2025 | -$13.51M | – |
| FY2024 | Dec 31, 2024 | -$19.55M | – |
| FY2023 | Dec 31, 2023 | -$14.78M | – |
| FY2022 | Dec 31, 2022 | -$24.65M | – |
| FY2021 | Dec 31, 2021 | -$24.60M | – |
| FY2020 | Dec 31, 2020 | -$33.82M | – |
| FY2019 | Dec 31, 2019 | -$43.43M | – |
| FY2018 | Dec 31, 2018 | -$41.94M | -1456.1% |
| FY2017 | Dec 31, 2017 | $3.09M | – |
| FY2016 | Dec 31, 2016 | -$25.69M | – |
| FY2015 | Dec 31, 2015 | -$24.27M | – |
| FY2014 | Dec 31, 2014 | -$35.96M | – |
| FY2013 | Dec 31, 2013 | -$2.16M | – |
Quarterly operating cash flow
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q2 FY2026 | Jun 30, 2026 | -$13.34M | – |
| Q1 FY2026 | Mar 31, 2026 | -$5.43M | – |
| Q4 FY2025 | Dec 31, 2025 | -$4.48M | – |
| Q3 FY2025 | Sep 30, 2025 | -$2.92M | – |
| Q2 FY2025 | Jun 30, 2025 | -$2.04M | – |
| Q1 FY2025 | Mar 31, 2025 | -$4.07M | – |
| Q4 FY2024 | Dec 31, 2024 | -$5.17M | – |
| Q3 FY2024 | Sep 30, 2024 | -$4.35M | – |
| Q2 FY2024 | Jun 30, 2024 | -$3.94M | – |
| Q1 FY2024 | Mar 31, 2024 | -$6.09M | – |
| Q4 FY2023 | Dec 31, 2023 | -$5.99M | – |
| Q3 FY2023 | Sep 30, 2023 | -$4.81M | – |
| Q2 FY2023 | Jun 30, 2023 | -$3.87M | – |
| Q1 FY2023 | Mar 31, 2023 | -$115.41K | – |
| Q4 FY2022 | Dec 31, 2022 | -$4.11M | – |
| Q3 FY2022 | Sep 30, 2022 | -$9.53M | – |
| Q2 FY2022 | Jun 30, 2022 | -$5.19M | – |
| Q1 FY2022 | Mar 31, 2022 | -$5.81M | – |
| Q4 FY2021 | Dec 31, 2021 | -$4.83M | – |
| Q3 FY2021 | Sep 30, 2021 | -$8.63M | – |
| Q2 FY2021 | Jun 30, 2021 | -$5.92M | – |
| Q1 FY2021 | Mar 31, 2021 | -$5.22M | – |
| Q4 FY2020 | Dec 31, 2020 | -$7.16M | – |
| Q3 FY2020 | Sep 30, 2020 | -$9.87M | – |
| Q2 FY2020 | Jun 30, 2020 | -$7.59M | – |
| Q1 FY2020 | Mar 31, 2020 | -$9.20M | – |
| Q4 FY2019 | Dec 31, 2019 | -$14.18M | – |
| Q3 FY2019 | Sep 30, 2019 | -$9.52M | – |
| Q2 FY2019 | Jun 30, 2019 | -$10.13M | – |
| Q1 FY2019 | Mar 31, 2019 | -$9.60M | – |
| Q4 FY2018 | Dec 31, 2018 | -$9.80M | – |
| Q3 FY2018 | Sep 30, 2018 | -$9.98M | -140.1% |
| Q2 FY2018 | Jun 30, 2018 | -$11.23M | – |
| Q1 FY2018 | Mar 31, 2018 | -$10.93M | – |
| Q4 FY2017 | Dec 31, 2017 | -$8.91M | – |
| Q3 FY2017 | Sep 30, 2017 | $24.89M | – |
| Q2 FY2017 | Jun 30, 2017 | -$6.84M | – |
| Q1 FY2017 | Mar 31, 2017 | -$6.04M | – |
| Q4 FY2016 | Dec 31, 2016 | -$8.93M | – |
| Q3 FY2016 | Sep 30, 2016 | -$4.66M | – |
See a number that looks wrong?